QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:DOMH

Dominari (DOMH) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free DOMH Stock Alerts
$2.70
-0.10 (-3.57%)
(As of 03:54 PM ET)
Compare
Today's Range
$2.70
▼
$2.83
50-Day Range
$1.95
▼
$3.14
52-Week Range
$1.76
▼
$3.76
Volume
12,066 shs
Average Volume
11,862 shs
Market Capitalization
$16.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
DOMH stock logo

About Dominari Stock (NASDAQ:DOMH)

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

DOMH Stock Price History

DOMH Stock News Headlines

April 11, 2024 | insidertrades.com
Dominari Holdings Inc. (NASDAQ:DOMH) President Buys $25,415.00 in Stock
April 9, 2024 | insidertrades.com
Anthony Hayes Acquires 3,944 Shares of Dominari Holdings Inc. (NASDAQ:DOMH) Stock
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 9, 2024 | insidertrades.com
Dominari Holdings Inc. (NASDAQ:DOMH) President Purchases $54,530.00 in Stock
April 17, 2024 | finance.yahoo.com
Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires
April 12, 2024 | americanbankingnews.com
Insider Buying: Dominari Holdings Inc. (NASDAQ:DOMH) President Buys 8,500 Shares of Stock
April 10, 2024 | americanbankingnews.com
Dominari (NASDAQ:DOMH) and Nomura (NYSE:NMR) Head to Head Analysis
April 1, 2024 | investorplace.com
DOMH Stock Earnings: Dominari Holdings Reported Results for Q4 2023
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
March 15, 2024 | prnewswire.com
Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance
March 12, 2024 | prnewswire.com
Dominari Securities LLC Expands Investment Banking Practice with Appointment of Experienced Financial Executive
March 7, 2024 | prnewswire.com
Dominari Securities LLC Continues to Add Depth with Three New Hires
March 7, 2024 | prnewswire.com
Dominari Securities LLC Continues to Add Depth with Three New Hires
March 6, 2024 | prnewswire.com
Dominari Securities LLC Welcomes Wealth Management Team Gotham Equities
March 5, 2024 | finance.yahoo.com
Dominari Securities LLC Welcomes Another Wealth Management Team
February 15, 2024 | finance.yahoo.com
Dominari Securities LLC Serves as Lead Underwriter for $5 Million Initial Public Offering for Unusual Machines
February 15, 2024 | prnewswire.com
Dominari Securities LLC Serves as Lead Underwriter for $5 Million Initial Public Offering for Unusual Machines
June 30, 2023 | finance.yahoo.com
Dominari Securities CEO, Kyle Wool, Shares Positive View of IPO Market on "Varnay & Co."
June 21, 2023 | finance.yahoo.com
Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"
June 5, 2023 | finance.yahoo.com
Kyle Wool, CEO of Dominari Securities, To Appear on Fox Business' Mornings With Maria Today
May 30, 2023 | finance.yahoo.com
Kyle Wool, CEO of Dominari Securities, To Appear on Fox Business' Varnay & Co. Today
May 24, 2023 | finance.yahoo.com
Dominari Inc. Expands Kyle Wool's Role at Company to Include CEO of Dominari Securities
April 27, 2023 | finance.yahoo.com
Dominari Financial CEO, Kyle Wool, Scheduled to Appear on Fox Business Network's "Mornings with Maria" on April 27
April 18, 2023 | finance.yahoo.com
Dominari Securities Acquires Broker Team with $700 Million in Assets Under Management
April 7, 2023 | marketwatch.com
Thursday 4/6 Insider Buying Report: PL, DOMH
April 3, 2023 | finance.yahoo.com
Dominari Holdings Appoints George Way Chief Financial Officer
March 28, 2023 | finance.yahoo.com
Kyle Wool Named CEO of Dominari Financial
See More Headlines
Receive DOMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Security brokers & dealers
Sub-Industry
N/A
Current Symbol
NASDAQ:DOMH
CUSIP
N/A
CIK
12239
Web
N/A
Phone
(112) 745-1374
Fax
703-992-9348
Employees
7
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($4.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-22,880,000.00
Net Margins
N/A
Pretax Margin
-1,122.22%
Return on Equity
-37.80%
Return on Assets
-34.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.51
Quick Ratio
17.51

Sales & Book Value

Annual Sales
$2.04 million
Price / Sales
8.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.90 per share
Price / Book
0.28

Miscellaneous

Outstanding Shares
5,930,000
Free Float
5,357,000
Market Cap
$16.43 million
Optionable
Not Optionable
Beta
0.91
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

DOMH Stock Analysis - Frequently Asked Questions

How have DOMH shares performed in 2024?

Dominari's stock was trading at $2.59 on January 1st, 2024. Since then, DOMH stock has increased by 4.2% and is now trading at $2.70.
View the best growth stocks for 2024 here.

Are investors shorting Dominari?

Dominari saw a decline in short interest in March. As of March 31st, there was short interest totaling 2,300 shares, a decline of 42.5% from the March 15th total of 4,000 shares. Based on an average trading volume of 12,300 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the stock are sold short.
View Dominari's Short Interest.

When is Dominari's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our DOMH earnings forecast.

How do I buy shares of Dominari?

Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:DOMH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media